By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Aradigm Corporation 

3929 Point Eden Way

Hayward  California  94545  U.S.A.
Phone: 510-265-9000 Fax: 510-265-0277


SEARCH JOBS


Industry
Biotechnology


Collaborations

Novo Nordisk A/S  Commercial agreement to develop AERx technology for the delivery of insulin, insulin analogues and other glucose-lowering agents for diabetes management.

GlaxoSmithKline  Agreement to develop AERx technology for the delivery of morphine and fentanyl for pain management.

University Of Torino  Aradigm has additional undisclosed partnerships with both platforms looking at developmental and marketed products.

GlaxoSmithKline (North Carolina) 





Company News
Aradigm (ARDM) Announces FDA Acceptance Of NDA For Linhaliq With Priority Review Status 9/25/2017 9:24:25 AM
Aradigm (ARDM) Announces FDA Acceptance Of NDA For Linhaliq With Priority Review Status 9/25/2017 6:01:24 AM
Aradigm (ARDM) To Host KOL Call On Infection Management In Non-Cystic Fibrosis Bronchiectasis Patients 9/15/2017 6:20:45 AM
Aradigm (ARDM) Awarded NIH Grant To Investigate The Treatment Of Pulmonary Non-Tuberculous Mycobacterial (PNTM) Infections With Linhaliq 8/15/2017 6:38:35 AM
Aradigm (ARDM) Announces Second Quarter 2017 Financial Results 8/10/2017 6:32:20 AM
Aradigm (ARDM) Submits New Drug Application (NDA) To FDA For U.S. Marketing Approval Of Linhaliq In Non-Cystic Fibrosis Bronchiectasis 7/27/2017 8:26:27 AM
Aradigm (ARDM) Announces First Quarter 2017 Financial Results 5/15/2017 7:19:32 AM
Aradigm (ARDM) Announces Fourth Quarter 2016 And Full Year Financial Results 3/28/2017 7:40:00 AM
Bay Area's Aradigm (ARDM) Stock Plunges After Posting Mixed-Data of Two Phase III Antibiotic Studies 12/1/2016 6:57:44 AM
Aradigm Corporation (ARDM) Announces Third Quarter 2016 Financial Results 11/9/2016 12:44:36 PM
12345678910...
//-->